Dexmedetomidine 

1. Introduction

Dexmedetomidine is a highly selective α₂-adrenergic receptor agonist used for:

  • ICU sedation
  • Procedural sedation
  • Analgosedation strategies

Unique feature: “Cooperative sedation” (arousable sedation with minimal respiratory depression)


2. Pharmacology

 Receptor Activity

  • α₂ : α₁ selectivity = ~1600:1
  • Acts on:
    • Locus coeruleus (brainstem) → sedation
    • Spinal cord (dorsal horn) → analgesia
    • Sympathetic neurons → ↓ catecholamine release

Mechanism of Action

  • Presynaptic α₂ activation → ↓ norepinephrine release
  • Postsynaptic activation → ↓ sympathetic outflow

 Results:

  • Sedation (natural sleep-like)
  • Analgesia
  • Anxiolysis
  • Sympatholysis

3. Pharmacokinetics

Parameter

Value

Route

IV infusion

Onset

5–10 min

Peak

15–30 min

Half-life

~2–3 hours

Context-sensitive half-time

Short (advantage in ICU)

Dose reduction in hepatic failure

4. Pharmacodynamics 

System

Effect

CNS

Sedation (resembles natural sleep)

Respiratory

Minimal depression (key advantage)

CVS

Bradycardia, hypotension

Analgesia

Mild to moderate

Endocrine

↓ catecholamines

5. Dosing in ICU

 Standard ICU Sedation

  • Loading dose (optional):
    0.5–1 µg/kg over 10 min (often avoided in ICU due to hypotension/bradycardia)
  • Maintenance infusion:
    0.2 – 0.7 µg/kg/hr
    (can go up to     1.5 µg/kg/hr in some protocols)

Special Situations

Condition

Dose Strategy

Elderly

Lower dose

Hepatic dysfunction

Reduce dose

Shock patients

Avoid or use cautiously

 6. Clinical Uses in CCM

1. ICU Sedation (MOST IMPORTANT)

  • Light to moderate sedation (RASS -2 to 0)
  • Facilitates:
    • Early extubation
    • Neurological assessment

 Preferred over benzodiazepines (per Society of Critical Care Medicine PADIS guidelines)

 2. Delirium Prevention & Management

  • Reduces ICU delirium vs benzodiazepines
  • Promotes natural sleep cycle

 3. Weaning & Extubation

  • Allows:
    • Awake, cooperative patient
    • Smooth ventilator weaning

 4. Procedural Sedation

  • Awake fiberoptic intubation
  • Bedside procedures

 5. Adjunct in Analgosedation

  • Reduces opioid requirement

 6. Alcohol Withdrawal

  • Controls sympathetic overactivity
  • Adjunct to benzodiazepines

 7. Advantages 

 No respiratory depression
 Arousable sedation
 Delirium reduction
 Analgesic sparing
 Sympatholysis (↓ HR, ↓ BP)
 Facilitates early extubation


 8. Adverse Effects

Cardiovascular

  • Bradycardia (most common)
  • Hypotension
  • Initial transient hypertension (with bolus)

Others

  • Dry mouth
  • Nausea
  • Withdrawal (rebound hypertension if abrupt stop)

9. Contraindications / Caution

Condition

Reason

Severe bradycardia

May worsen

Heart block

AV conduction suppression

Hypovolemia

Hypotension risk

Shock

Reduced sympathetic tone

Hepatic failure

Reduced clearance

10. Comparison with Other Sedatives 

Feature

Dexmedetomidine

Propofol

Midazolam

Sedation type

Cooperative

Deep

Deep

Respiratory depression

 Minimal

 Yes

Yes

Delirium risk

↓

Neutral

↑

Analgesia

Mild

None

None

Hemodynamics

Bradycardia

Hypotension

Stable

11. Evidence & Guidelines 

 Society of Critical Care Medicine PADIS 2018 Guidelines

  • Recommend:
    • Dexmedetomidine or propofol over benzodiazepines
    • For:
      • Mechanically ventilated adults
      • Delirium prevention

 Key Trials

  • MENDS Trial → ↓ delirium vs midazolam
  • SEDCOM Trial → ↓ ventilation duration
  • PRODEX Trial → comparable to propofol

 12. VIVA Exam Questions

✔ Why no respiratory depression?
→ Acts on locus coeruleus, not GABA receptors

✔ Why bradycardia?
→ Central sympatholysis + vagal predominance

✔ Why preferred in delirium?
→ Mimics natural sleep, ↓ GABA delirium effect